Rezultaty - Andrew J. Armstrong

Redukuj rezultaty
  1. 1
    Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer

    Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer od Emmanuel S. Antonarakis, Andrew J. Armstrong

    Wydane 2011
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

    Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer od Rhonda L. Bitting, Andrew J. Armstrong

    Wydane 2013
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Reply to R. Sun et al

    Reply to R. Sun et al od Andrew J. Armstrong, Brad Rosbrook, Shunsuke Yamada

    Wydane 2022
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Carta
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin

    Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin od Andrew J. Armstrong, Daniel J. George, Susan Halabi

    Wydane 2012
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

    Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease od Michael R. Harrison, Daniel J. George, Wong, Andrew J. Armstrong

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

    Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting od Emmanuel S. Antonarakis, Andrew J. Armstrong, Scott M. Dehm, Jun Luo

    Wydane 2016
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations

    Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations od Changxue Lu, Landon C. Brown, Emmanuel S. Antonarakis, Andrew J. Armstrong, Jun Luo

    Wydane 2020
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer

    Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer od Kathryn E. Ware, Mariano A. Garcia‐Blanco, Andrew J. Armstrong, Scott M. Dehm

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    The role of epithelial plasticity in prostate cancer dissemination and treatment resistance

    The role of epithelial plasticity in prostate cancer dissemination and treatment resistance od Rhonda L. Bitting, Daneen Schaeffer, Jason A. Somarelli, Mariano A. Garcia‐Blanco, Andrew J. Armstrong

    Wydane 2014
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

    Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide od Krista Noonan, Scott North, Rhonda L. Bitting, Andrew J. Armstrong, Susan Ellard, K.N. Chi

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  11. 11
    Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer

    Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer od Andrew J. Armstrong, Elizabeth Garrett‐Mayer, Ronald de Wit, Ian F. Tannock, Mario A. Eisenberger

    Wydane 2009
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  12. 12
    Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond

    Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond od Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang

    Wydane 2018
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  13. 13
    Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey

    Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey od Hannah D. McManus, Tanya B. Dorff, Alicia K. Morgans, Oliver Sartor, Neal D. Shore, Andrew J. Armstrong

    Wydane 2024
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  14. 14
    A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis

    A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis od Andrew J. Armstrong, Elizabeth Garrett‐Mayer, Yi-Chun Ou Yang, Ronald de Wit, Ian F. Tannock, Mario A. Eisenberger

    Wydane 2007
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  15. 15
    Molecular determinants for enzalutamide-induced transcription in prostate cancer

    Molecular determinants for enzalutamide-induced transcription in prostate cancer od Fuwen Yuan, William Hankey, Dayong Wu, Hongyan Wang, Jason A. Somarelli, Andrew J. Armstrong, Jiaoti Huang, Zhong Chen, Qianben Wang

    Wydane 2019
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  16. 16
    New and Emerging Therapies for Bone Metastases in Genitourinary Cancers

    New and Emerging Therapies for Bone Metastases in Genitourinary Cancers od Philip J. Saylor, Andrew J. Armstrong, Karim Fizazi, Stephen J. Freedland, Fred Saad, Matthew R. Smith, Bertrand Tombal, Kenneth J. Pienta

    Wydane 2012
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  17. 17
    Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

    Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer od Andrew J. Armstrong, Mario A. Eisenberger, Susan Halabi, Stéphane Oudard, David M. Nanus, Daniel P. Petrylak, Oliver Sartor, Howard I. Scher

    Wydane 2011
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  18. 18
    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy od Susan Halabi, Andrew J. Armstrong, Oliver Sartor, Johann S. de Bono, Ellen B. Kaplan, Chen‐Yen Lin, Nicole Solomon, Eric J. Small

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  19. 19
    Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma

    Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma od Matthew Labriola, Kristen A. Batich, Jason Zhu, Megan McNamara, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, Tian Zhang

    Wydane 2019
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  20. 20
    Novel therapies are changing treatment paradigms in metastatic prostate cancer

    Novel therapies are changing treatment paradigms in metastatic prostate cancer od Eric R. Powers, Georgia Sofia Karachaliou, Chester Kao, Michael R. Harrison, Christopher Hoimes, Daniel J. George, Andrew J. Armstrong, Tian Zhang

    Wydane 2020
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: